Skip to main content

alza 18 Pill - yellow capsule/oblong

Pill with imprint alza 18 is Yellow, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release 18 mg. It is supplied by Watson Pharmaceuticals.

Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 18 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for alza 18

Methylphenidate hydrochloride extended-release 18 mg alza 18
Methylphenidate hydrochloride extended-release 18 mg alza 18

Methylphenidate Hydrochloride Extended-Release

alza 18
18 mg
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
butylated hydroxytoluene, carnauba wax, cellulose acetate, phosphoric acid, sodium chloride, propylene glycol, stearic acid, succinic acid, ferrosoferric oxide, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-2715 (Discontinued) Watson Pharmaceuticals, Inc.
50458-0585 Ortho-McNeil Pharmaceutical, LLC
68084-0890 (Discontinued) Amerisource Health Services
54868-4489 (Discontinued) Physicians Total Care Inc. (repackager)
55289-0835 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "alza 18"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.